|
시장보고서
상품코드
1907968
유전자 편집 시장 : 제품별, 기술별, 용도별, 최종 사용자별, 지역별Gene Editing Market, By Product, By Technology, By Application, By End User, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
유전자 편집 시장은 2025년에 48억 달러로 평가되었고, 2032년까지 95억 1,000만 달러에 이를 것으로 예측됩니다. 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 10.2%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 48억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측기간 CAGR(2025-2032년) | 10.20% | 예측 금액(2032년) | 95억 1,000만 달러 |
유전자 편집은 유기체의 DNA에 표적화된 변화를 가할 수 있는 유전공학의 한 형태입니다. 기술의 발전은 치료 목적의 유전자 변형 및 형질 개선에 비용 효율적인 옵션을 제공하여 유전자 편집의 적용 범위와 효율성을 크게 향상 시켰습니다. 세계의 유전자 편집 시장은 다양한 연구, 치료 및 농업 응용 분야에서 유전자 편집과 관련된 도구, 제품 및 서비스를 포함합니다. 지난 10년간 유전자 편집은 질병 치료와 농업 분야에서 큰 잠재력을 지닌 최첨단 기술이 되었습니다. 정확성, 안전성 및 도입 방법의 지속적인 개선으로 기존 산업에 혁신을 가져와 현대 생명공학을 변화시킬 것으로 기대되고 있습니다.
시장 역학
세계의 유전자 편집 시장은 민간 및 공적 자금을 통한 생명공학 연구개발에 대한 투자 확대에 견인되고 있습니다. CRISPR-Cas9를 비롯한 유전자 편집 툴의 진보는 치료 응용 가능성을 넓혀 시장 성장을 가속하고 있습니다. 시퀀싱 및 합성 비용의 감소도 유전자 편집 기술에 대한 접근성 향상에 기여합니다. 그러나 유전자 편집 작물의 상업화와 치료 제품에 대한 규제 우려가 시장 성장의 억제요인으로 남아 있습니다. 게다가, 확립된 전달 방법의 부족과 오프 타겟 편집은 여전히 주요 과제입니다. 생체내 전달 시스템의 개발은 새로운 질병 치료 영역으로의 확대 기회를 제공합니다. 농업 분야에서의 상업적 응용의 성공은 장기적으로 유망한 전망을 보여줍니다.
이 보고서의 주요 특징
- 본 보고서는 세계의 유전자 편집 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
- 또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품의 상시와 승인, 시장 동향, 지역별 전망, 주요기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 세계 유전자 편집 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개 변수를 기반으로 게시됩니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- '세계 유전자 편집 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계 유전자 편집 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 기업 합병 및 인수(M&A) 시나리오
- 업계 동향
제4장 세계의 유전자 편집 시장 : 제품별(2020-2032년)
- 키트
- 시약
- 소프트웨어
제5장 세계의 유전자 편집 시장 : 기술별(2020-2032년)
- CRISPR(Clustered Regularly Interspaced Short Palindromic Repeats)
- TALEN(Transcription Activator-Like Effector Nuclease)
- ZNF(Zinc Finger Nucleases)
- 메가뉴클레아제
- 프라임 에디팅
- 기타(PiggyBac 등)
제6장 세계의 유전자 편집 시장 : 용도별(2020-2032년)
- 세포주 공학
- 유전자 공학
- 신약개발
- 임상 진단
- 이종이식
- 농업
제7장 세계의 유전자 편집 시장 : 최종 사용자별(2020-2032년)
- 제약 및 바이오테크놀러지 기업
- 학술기관 및 연구기관
- CRO(의약품 개발 업무 수탁 기관)
- 진단기업
- 기타
제8장 세계의 유전자 편집 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제9장 경쟁 구도
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Horizon Discovery
- Sangamo Therapeutics
- Cellectis
- Genomatix
- Integrated DNA Technologies
- New England Biolabs
- Takara Bio
- Bio-Rad Laboratories
- Ginkgo Bioworks
제10장 애널리스트의 제안
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map(COM)
제11장 참고문헌과 분석 방법
- 참고문헌
- 분석 방법
- Coherent Market Insights에 대해
Gene Editing Market is estimated to be valued at USD 4.80 Bn in 2025 and is expected to reach USD 9.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4.80 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 10.20% | 2032 Value Projection: | USD 9.51 Bn |
Gene editing is a type of genetic engineering which allows targeted changes to be made to an organism's DNA. Technologies, have greatly expanded the scope and efficiency of gene editing by providing cost-effective options for therapeutic modifications and trait improvements. The global gene editing market encompasses tools, products, and services related to gene editing of genomes in various research, therapeutic, and agricultural applications. Over the past decade, gene editing has become a frontier technology with significant potential for disease treatment and agriculture. With continued improvements in precision, safety, and delivery methods, is anticipated to disrupt established industries and transform modern biotechnology.
Market Dynamics
The global gene editing market is driven by growing investments in biotechnology research and development from both private and public sources. Advancements in CRISPR-Cas9 and other gene editing tools have expanded the potential for therapeutic applications, boosting market growth. Reduced costs of sequencing and synthesis are also improving access to gene editing technologies. However, regulatory concerns around the commercialization of gene edited crops and therapeutic products continue to restrain market growth. Additionally, lack of established delivery methods and off-target editing remain major challenges. The development of in vivo delivery systems presents an opportunity for expansion into new disease treatment areas. Successful commercial applications in agriculture also present a promising prospect over the long term.
Key Features of the Study
- This report provides in-depth analysis of the global gene editing market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global gene editing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Horizon Discovery, Sangamo Therapeutics, Cellectis, Genomatix, Integrated DNA Technologies, New England Biolabs, Takara Bio, Bio-Rad Laboratories, and Ginkgo Bioworks
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global gene editing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene editing market
Market Segmentation
- Product Insights (Revenue, USD Bn, 2025 - 2032)
- Kits
- Reagents
- Software
- Technology Insights (Revenue, USD Bn, 2025 - 2032)
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Transcription Activator-Like Effector Nuclease (TALEN)
- ZFN (Zinc Finger Nucleases)
- Meganucleases
- Prime Editing
- Others (PiggyBac, etc.)
- Application Insights (Revenue, USD Bn, 2025 - 2032)
- Cell Line Engineering
- Genetic Engineering
- Drug Discovery
- Clinical Diagnostics
- Xenotransplantation
- Agriculture
- End User Insights (Revenue, USD Bn, 2025 - 2032)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Diagnostic Companies
- Others
- Regional Insights (Revenue, USD Bn, 2025 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Horizon Discovery
- Sangamo Therapeutics
- Cellectis
- Genomatix
- Integrated DNA Technologies
- New England Biolabs
- Takara Bio
- Bio-Rad Laboratories
- Ginkgo Bioworks
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Gene Editing Market, By Product
- Global Gene Editing Market, By Technology
- Global Gene Editing Market, By Application
- Global Gene Editing Market, By End User
- Global Gene Editing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Gene Editing Market, By Product, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Gene Editing Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Transcription Activator-Like Effector Nuclease (TALEN)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- ZFN (Zinc Finger Nucleases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Meganucleases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prime Editing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (PiggyBac, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Gene Editing Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cell Line Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Genetic Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Xenotransplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Agriculture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Gene Editing Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Gene Editing Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- CRISPR Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Editas Medicine
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intellia Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Horizon Discovery
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sangamo Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cellectis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Genomatix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integrated DNA Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- New England Biolabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ginkgo Bioworks
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
샘플 요청 목록